Cancer Genetics, Inc.

Get the CGIX Research Report and Also Receive Our Top Trades for 2016! The company reported total revenue of $27 million for 2016, compared to $18 million in 2015, an annual increase of 50%. Total revenue in the fourth quarter of 2016 was $7.2 million, compared to...

Flexion Therapeutics, Inc.

Get the FLXN Research Report and Also Receive Our Top Trades for 2016! In February 2017, the Company announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) for Zilretta in osteoarthritis (OA) of the knee. Under the...

HTG Molecular Diagnostics, Inc.

Get the HTGM Research Report and Also Receive Our Top Trades for 2016! Revenue for the fourth quarter of 2016 was $1.5 million. Net loss from operations was $5.2 million for the fourth quarter of 2016, compared to $5.3 million for the fourth quarter of 2015. Net loss...

Therapix Biosciences Ltd.

Get the TRPX Research Report and Also Receive Our Top Trades for 2016! Therapix Biosciences Ltd. is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists, focused on creating and enhancing a portfolio of...